Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)

Title
Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)
Authors
Keywords
-
Journal
JOURNAL OF RHEUMATOLOGY
Volume 45, Issue 11, Pages 1608-1608
Publisher
The Journal of Rheumatology
Online
2018-11-01
DOI
10.3899/jrheum.170429.c1

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now